Skip to content

13F-HR filed by Knoll Capital Management, LLC

Knoll Capital Management, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 33 holding rows worth $171,139,000.

Accession
0001104659-22-118490
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 33 entries on the cover page, a total value of $171,139,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $171,139,000 with VALUE read as thousands by filing date, 13F file number 028-11424. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM900,844$136,181,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,877,305$10,025,000thousands by filing date
ENTERA BIO LTDM40527109SHS2,484,275$2,584,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW173,864$2,220,000thousands by filing date
Anavex Life Sciences Corp003279730COM NEW210,789$2,175,000thousands by filing date
Orgenesis, Inc.68619K105COM1,316,364$1,869,000thousands by filing date
CVS Health Corporation126650100COM14,500$1,384,000thousands by filing date
BOOZ ALLEN HAMILTON HLDG CORP CL A099502106Stock13,000$1,200,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM2,100$1,066,000thousands by filing date
Applied Therapeutics Inc03828A101Common Stock1,082,123$1,006,000thousands by filing date
Altria Group Inc02209S103COM22,700$917,000thousands by filing date
Visa Inc92826C839COM4,850$862,000thousands by filing date
BLACKSTONE GROUP LP09253U108COM UNIT LTD10,000$838,000thousands by filing date
CORBUS PHARMACEUTICALS HLDGS21833P103COM5,045,870$833,000thousands by filing date
CORNING INC219350105COM26,600$773,000thousands by filing date
AGNICO EAGLE MINES LTD COM008474108Stock15,393$650,000thousands by filing date
MAG SILVER CORP55903Q104COMMON STOCK-FO48,000$599,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM585,966$586,000thousands by filing date
FRANCO NEV CORP COM351858105Stock4,900$585,000thousands by filing date
MAVERIX METALS INC57776F405COMMON STOCK-FO165,000$553,000thousands by filing date
SILVERCREST METALS INC828363101COM100,000$553,000thousands by filing date
WHEATON PRECIOUS METALS CORP COM962879102Stock16,500$534,000thousands by filing date
OSISKO GOLD ROYALTIES LTD68827L101COM235,000$529,000thousands by filing date
SEABRIDGE GOLD INC811916105COM *D*41,000$487,000thousands by filing date
PAN AMERN SILVER CORP697900108COM29,500$468,000thousands by filing date
EQUINOX GOLD CORP29446Y502COM99,000$361,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM5,000$349,000thousands by filing date
ABEONA THERAPEUTICS INC00289Y107COM88,629$269,000thousands by filing date
BIOXCEL THERAPEUTICS INC09075P105COM20,000$236,000thousands by filing date
CONTEXT THERAPEUTICS INC21077P108COM139,520$155,000thousands by filing date
ANNOVIS BIO INC03615A108COM14,210$147,000thousands by filing date
ORAMED PHARMACEUTICALS INC68403P203COM NEW20,000$130,000thousands by filing date
SOLIGENIX INC834223307COM34,766$15,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-118490this filing2022-11-14acceptance time not in the bulk data set